Biotia Raises $9M From Digitaldx Ventures
New York-based Biotia, clinical metagenomics solutions, raised $9M Series A+ from DigitalDx Ventures. Proceeds will scale its New York City laboratory, launch additional diagnostics in women's...
Biotia raises $9M in a series a+ from DigitalDx Ventures.
New York-based Biotia clinical metagenomics solutions. Niamh O'Hara (CEO leads the company.
Biotia will use the capital to scale its New York City laboratory, launch additional diagnostics in women's health, and expand into orthopedic diagnostics..
"{"quote_text"=>"This funding enables us to do what matters most: expand advanced diagnostics available for patients suffering from chronic infections who have been failed by standard laboratory methods.", "quote_speaker"=>"Niamh O'Hara"}," said Niamh O'Hara (CEO, cofounder),.
| Company | Biotia |
|---|---|
| HQ | New York |
| Round | Series A+ |
| Amount | $9M |
| Lead investor | DigitalDx Ventures |
| Founders | Niamh O'Hara (CEO, cofounder), Chris Mason (global director |
| Sector | healthcare |
| Source | PR Newswire |
ABOUT THIS STORY
- Desk
- Articles
- Filed
- Oct 1, 2026 · 3:04 PM
- By
- Traded Media